Exchanges: NASDAQ | NYSE | XLON | AMS | ADS | TSE | BRU
Wednesday June 26, 2019 Change 47.72% Price $0.07
Chart period: 2019-03-27 - 2019-06-26
VOLUME
Buy
TREND
Sell
MV LONG
Sell

MV SHORT
Buy

PIVOT
Buy

MACD
Sell

Will ARGS stock price go up or down on Thu, 27 Jun 2019?

Predict

Argos Therapeutics Forecast and Stock Analysis

Technical ARGS stock analysis for Wednesday June 26, 2019.

Hold candidate since 2019-06-26


Argos Therapeutics gained 47.72% in the last trading day ( Wednesday, 26th Jun 2019 ), rising from $0.05 to $0.07 During day the stock fluctuated 52.29% from a day low at $0.05 to a day high of $0.07. The price has been going up and down for this period, and there has been a 13.25% gain for the last 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 23 154 more shares were traded than the day before. In total, 24 580 shares bought and sold for approximately $1 670.21.

Quick summary:

  • 30 day high of the ARGS stock price was $0.08 and low was $0.04.
  • 90 day high was $0.09 and low was $0.04.
  • 52 week high for the Argos Therapeutics - $0.25 and low - $0.02.

Trend

Argos Therapeutics lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.07 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -21.66% during the next 3 months and, with 90% probability hold a price between $0.03 and $0.06 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

A buy signal was issued from a pivot bottom point on Tuesday June 25, 2019, which indicates further gains until a new top pivot has been found. Argos Therapeutics has rising volume and follows the last lift in the price. This considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. Argos Therapeutics holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $0.07. On a fall, the stock will find some support from the short-term average at $0.07. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 45 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $0.06 and $0.06.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Argos Therapeutics finds support just below today's level at $0.06. If this is broken, then the next support from accumulated volume will be at $0.06 and $0.06.

Support: $0.06 Price: $0.07 Resistance: $0.07

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.02 between high and low, or 52.29%. For the last week, the stock has had a daily average volatility of 46.61%.

Our recommended stoploss: $0.06 (-5.78%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 1 days ago.)

46.61 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Evaluation:

Argos Therapeutics holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Hold/Accumulate.

Hold/Accumulate Upgraded

Will ARGS stock price go up or down on Thu, 27 Jun 2019?

Predict

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank